No Data
No Data
Express News | Everbright: Multiple drugs have made progress, with rapid development in the field of liver fibrosis treatment.
Everbright Securities: Interest rate decisions add volatility to the market, while the opportunity for a stable transition in the USA economy is increasing.
The Federal Reserve implemented a further rate cut of 25 basis points to a range of 4.25 to 4.50% in December, which aligns with market expectations. Everbright's international securities strategist Wu Lixian believes that this interest rate meeting brought a significant amount of information, providing at least three important insights for every investor. First, at this interest rate meeting, the Federal Reserve announced a new round of dot plots. If compared to the previous dot plot from September, the 19 Federal Reserve officials' expectations for the target interest rate by the end of 2025 have been revised upward from a median of 3.375% three months ago to the latest forecast of 3.875%. In other words, over the past three months, the Federal Reserve's outlook for next year.
Express News | Everbright's chief Analyst Zhang Xu: It is expected that there will be a reduction in interest rates by 20 to 30 basis points throughout next year.
Hong Kong stocks fluctuated | China-Affiliated Brokerage surged rapidly in the afternoon, with Institutions stating that multiple Bullish factors are catalyzing the Brokerage market, indicating that the Sector is expected to see both performance and valua
China-Affiliated Brokerage stocks surged rapidly in the afternoon. As of the time of publication, Guolian (01456) rose by 4.09%, trading at 4.84 Hong Kong dollars; China Merchants (06099) rose by 2.96%, trading at 16.02 Hong Kong dollars; Everbright (06178) rose by 1.1%, trading at 8.24 Hong Kong dollars; SWHY (06806) rose by 0.83%, trading at 2.44 Hong Kong dollars.
China Court Rules Litigation Case Against Jin Tong Ling to Proceed; Shares Fall 8%
Everbright (06178.HK): Jin Tong Ling Technology Group faces a lawsuit with claims nearing 0.76 million yuan.
Everbright (06178.HK) announced that it has received a summons and civil ruling from the Intermediate People's Court of Nanjing, Jiangsu Province. A total of 10 individual investors, including Ye Xiaoming and Yu Mengxian, have filed a lawsuit against Jin Tong Ling Technology Group (300091.SZ) and related persons and institutions for securities false statement liability disputes. The company is one of the 24 defendants in the lawsuit, serving as the independent financial advisor for Jin Tong Ling's 2018 issuance of shares to acquire assets and raise supporting funds. Currently, the total amount claimed by the 10 plaintiffs is 0.7564 million yuan. Given the intended hearing of the litigation case.
No Data